Contact | Print version | PDF version | Send article | RSS feed

ActivBiotics Set to Sell Proprietary Assets, Including Drug Product Candidates

10 Mar 2008 - Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, confirmed that the sale of ActivBiotics' proprietary assets will be carried out through a sealed bid at 12:00 PM on March 14, 2008. There has been substantial interest from various parties about different aspects of the technology. "With 48 bid packages being reviewed by companies, in addition to comprehensive due diligence, I believe we'll be able to successfully monetize the assets of the company," said Joseph F. Finn, Jr. "However, because different parties are interested in different assets, it is unlikely that sale of all three assets will go to a single buyer," added Finn.